lexiara

Recital 50

(50) The Commission should establish a so-called Consultation Forum. The Consultation Forum should ensure the balanced participation of Member States’ representatives and representatives of relevant stakeholders, including environmental organisations, representatives of healthcare and patient association as well as representatives of manufacturers, operators and certified persons. The Consultation Forum should, where relevant, involve the European Medicines Agency.

· All articles ·

Source: EUR-Lex (Cellar) · retrieved 2026-11-07 · Text as adopted (Official Journal); later amendments are not incorporated in this text.